News Snapshot:
In today’s briefing: - China Mobile (600941 CH): Potential Index Fast Entry - 1H22 Obex Research Long Portfolio - Shanghai Junshi Bioscience (1877.HK/688180.CH) – Behind the “break Up” with AstraZeneca - Morning Views Asia: China Jinmao Holdings, China SCE, Guangzhou R&F Properties Before it’s here, it’s on Smartkarma